IBDEI15U ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,401,0)
 ;;=RISK FACTOR REDUCTION-IND^7^34
 ;;^UTILITY(U,$J,358.4,402,0)
 ;;=OTHER^3^35
 ;;^UTILITY(U,$J,358.4,403,0)
 ;;=EDUCATION/TRAINING^1^35
 ;;^UTILITY(U,$J,358.4,404,0)
 ;;=MEDICAL NUTRITION THERAPY^2^35
 ;;^UTILITY(U,$J,358.4,405,0)
 ;;=WOUND TREATMENT^5^35
 ;;^UTILITY(U,$J,358.4,406,0)
 ;;=PROLONGED SERVICES^4^35
 ;;^UTILITY(U,$J,358.4,407,0)
 ;;=DIABETES^1^36
 ;;^UTILITY(U,$J,358.4,408,0)
 ;;=NEW PATIENT^3^37
 ;;^UTILITY(U,$J,358.4,409,0)
 ;;=ESTABLISHED PATIENT^2^37
 ;;^UTILITY(U,$J,358.4,410,0)
 ;;=CONSULTATIONS^4^37
 ;;^UTILITY(U,$J,358.4,411,0)
 ;;=PROVIDER WEEKLY VISIT^1^37
 ;;^UTILITY(U,$J,358.4,412,0)
 ;;=ACCESS^2^38
 ;;^UTILITY(U,$J,358.4,413,0)
 ;;=DIALYSIS PROCEDURES^3^38
 ;;^UTILITY(U,$J,358.4,414,0)
 ;;=ESRD HOME SERVICES^4^38
 ;;^UTILITY(U,$J,358.4,415,0)
 ;;=HEMODIALYSIS OVERSIGHT^5^38
 ;;^UTILITY(U,$J,358.4,416,0)
 ;;=LAB^7^38
 ;;^UTILITY(U,$J,358.4,417,0)
 ;;=MEDICATIONS^8^38
 ;;^UTILITY(U,$J,358.4,418,0)
 ;;=MONITORING^9^38
 ;;^UTILITY(U,$J,358.4,419,0)
 ;;=OTHER^10^38
 ;;^UTILITY(U,$J,358.4,420,0)
 ;;=PATIENT EDUCATION/TEACHING^11^38
 ;;^UTILITY(U,$J,358.4,421,0)
 ;;=PATIENT MANAGEMENT^12^38
 ;;^UTILITY(U,$J,358.4,422,0)
 ;;=SUPPLIES^13^38
 ;;^UTILITY(U,$J,358.4,423,0)
 ;;=VACCINATIONS^14^38
 ;;^UTILITY(U,$J,358.4,424,0)
 ;;=DAILY DIALYSIS TXMT^1^38
 ;;^UTILITY(U,$J,358.4,425,0)
 ;;=INPATIENT DIALYSIS^6^38
 ;;^UTILITY(U,$J,358.4,426,0)
 ;;=HEMODIALYSIS-ESRD^14^39
 ;;^UTILITY(U,$J,358.4,427,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^23^39
 ;;^UTILITY(U,$J,358.4,428,0)
 ;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^39
 ;;^UTILITY(U,$J,358.4,429,0)
 ;;=COMPLICATIONS/OTHER^4^39
 ;;^UTILITY(U,$J,358.4,430,0)
 ;;=CYSTIC KIDNEY DISEASE^5^39
 ;;^UTILITY(U,$J,358.4,431,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^39
 ;;^UTILITY(U,$J,358.4,432,0)
 ;;=FLUID/ELECTROLYTE DISORDER^8^39
 ;;^UTILITY(U,$J,358.4,433,0)
 ;;=GENERAL SYMPTOMS^9^39
 ;;^UTILITY(U,$J,358.4,434,0)
 ;;=GENITAL/URINARY^10^39
 ;;^UTILITY(U,$J,358.4,435,0)
 ;;=HEMATOLOGY^12^39
 ;;^UTILITY(U,$J,358.4,436,0)
 ;;=HYPERTENSION^15^39
 ;;^UTILITY(U,$J,358.4,437,0)
 ;;=INFECTIOUS DISEASE^16^39
 ;;^UTILITY(U,$J,358.4,438,0)
 ;;=NEPHRITIS GLUMERULONEPHRITIS^18^39
 ;;^UTILITY(U,$J,358.4,439,0)
 ;;=NEPHRITIS INTERSTITIAL^19^39
 ;;^UTILITY(U,$J,358.4,440,0)
 ;;=NEPHROTIC SYNDROME^21^39
 ;;^UTILITY(U,$J,358.4,441,0)
 ;;=OBSTRUCTIVE UROPATHY^22^39
 ;;^UTILITY(U,$J,358.4,442,0)
 ;;=TRANSPLANT^25^39
 ;;^UTILITY(U,$J,358.4,443,0)
 ;;=CKD/KIDNEY DISEASE^3^39
 ;;^UTILITY(U,$J,358.4,444,0)
 ;;=HEMODIALYSIS-AKI^13^39
 ;;^UTILITY(U,$J,358.4,445,0)
 ;;=ACUTE KIDNEY INJURY^1^39
 ;;^UTILITY(U,$J,358.4,446,0)
 ;;=GLOMERULAR DISEASE^11^39
 ;;^UTILITY(U,$J,358.4,447,0)
 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^17^39
 ;;^UTILITY(U,$J,358.4,448,0)
 ;;=NEPHROLITHASIS^20^39
 ;;^UTILITY(U,$J,358.4,449,0)
 ;;=POISONING & INTOXICATIONS^24^39
 ;;^UTILITY(U,$J,358.4,450,0)
 ;;=DIALYSIS^7^39
 ;;^UTILITY(U,$J,358.4,451,0)
 ;;=IMMUNIZATION^10^40
 ;;^UTILITY(U,$J,358.4,452,0)
 ;;=INJECTION/INFUSION^12^40
 ;;^UTILITY(U,$J,358.4,453,0)
 ;;=SKIN TEST^26^40
 ;;^UTILITY(U,$J,358.4,454,0)
 ;;=NURSING PROCEDURES^18^40
 ;;^UTILITY(U,$J,358.4,455,0)
 ;;=SPLINTS^27^40
 ;;^UTILITY(U,$J,358.4,456,0)
 ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENITALIA^24^40
 ;;^UTILITY(U,$J,358.4,457,0)
 ;;=REPAIR-SIMPLE FACE,MUCOUS^23^40
 ;;^UTILITY(U,$J,358.4,458,0)
 ;;=MODERATE SEDATION^15^40
 ;;^UTILITY(U,$J,358.4,459,0)
 ;;=INTEGUMENTARY SYSTEM^13^40
 ;;^UTILITY(U,$J,358.4,460,0)
 ;;=MUSCULOSKELETAL^16^40
 ;;^UTILITY(U,$J,358.4,461,0)
 ;;=CASTS/STRAPS^4^40
 ;;^UTILITY(U,$J,358.4,462,0)
 ;;=RESPIRATORY SYSTEM^25^40
 ;;^UTILITY(U,$J,358.4,463,0)
 ;;=CARDIOVASCULAR SYSTEM^3^40
 ;;^UTILITY(U,$J,358.4,464,0)
 ;;=DIGESTIVE SYSTEM^7^40
 ;;^UTILITY(U,$J,358.4,465,0)
 ;;=URINARY SYSTEM^28^40
 ;;^UTILITY(U,$J,358.4,466,0)
 ;;=MALE GENITAL SYSTEM^14^40
 ;;^UTILITY(U,$J,358.4,467,0)
 ;;=FEMALE GENITAL SYSTEM^9^40
 ;;^UTILITY(U,$J,358.4,468,0)
 ;;=NERVOUS SYSTEM^17^40
 ;;^UTILITY(U,$J,358.4,469,0)
 ;;=EYE & OCULAR ADNEXA^8^40
 ;;^UTILITY(U,$J,358.4,470,0)
 ;;=AUDITORY SYSTEM^1^40
 ;;^UTILITY(U,$J,358.4,471,0)
 ;;=REPAIR-INTER SCALP/NECK/TRNK/EXTREM^22^40
 ;;^UTILITY(U,$J,358.4,472,0)
 ;;=REPAIR-INTER FACE/EARS/EYELID/NOSE/LIP^20^40
 ;;^UTILITY(U,$J,358.4,473,0)
 ;;=REPAIR-INTER HANDS/FEET/EXT GENITALIA^21^40
 ;;^UTILITY(U,$J,358.4,474,0)
 ;;=BURNS^2^40
 ;;^UTILITY(U,$J,358.4,475,0)
 ;;=DESTRUCTION BENIGN LESIONS^6^40
 ;;^UTILITY(U,$J,358.4,476,0)
 ;;=PSYCHIATRY^19^40
 ;;^UTILITY(U,$J,358.4,477,0)
 ;;=CRITICAL CARE/EMERGENT^5^40
 ;;^UTILITY(U,$J,358.4,478,0)
 ;;=INJECTION ADMIN^11^40
 ;;^UTILITY(U,$J,358.4,479,0)
 ;;=EMERGENCY DEPT VISIT^2^41
 ;;^UTILITY(U,$J,358.4,480,0)
 ;;=TRIAGE ONLY (NO MD SEEN)^1^41
 ;;^UTILITY(U,$J,358.4,481,0)
 ;;=CRITICAL CARE^3^41
 ;;^UTILITY(U,$J,358.4,482,0)
 ;;=ED COMMON DIAGNOSES^1^42
 ;;^UTILITY(U,$J,358.4,483,0)
 ;;=ADMINISTRATIVE TOPICS^2^42
 ;;^UTILITY(U,$J,358.4,484,0)
 ;;=ANGINA^3^42
 ;;^UTILITY(U,$J,358.4,485,0)
 ;;=ATHEROSCLEROSIS^4^42
 ;;^UTILITY(U,$J,358.4,486,0)
 ;;=CARDIOVASCULAR^5^42
 ;;^UTILITY(U,$J,358.4,487,0)
 ;;=DERMATOLOGY^10^42
 ;;^UTILITY(U,$J,358.4,488,0)
 ;;=EAR DISORDERS^11^42
 ;;^UTILITY(U,$J,358.4,489,0)
 ;;=EENT^12^42
 ;;^UTILITY(U,$J,358.4,490,0)
 ;;=ENDOCRINE/METABOLIC^13^42
 ;;^UTILITY(U,$J,358.4,491,0)
 ;;=EYE DISORDERS^14^42
 ;;^UTILITY(U,$J,358.4,492,0)
 ;;=EYE INJURY^15^42
 ;;^UTILITY(U,$J,358.4,493,0)
 ;;=GASTROENTEROLOGY^16^42
 ;;^UTILITY(U,$J,358.4,494,0)
 ;;=GU/RENAL^17^42
 ;;^UTILITY(U,$J,358.4,495,0)
 ;;=HEADACHE^18^42
 ;;^UTILITY(U,$J,358.4,496,0)
 ;;=HEART FAILURE^19^42
 ;;^UTILITY(U,$J,358.4,497,0)
 ;;=HEART VALVE DISEASE^20^42
 ;;^UTILITY(U,$J,358.4,498,0)
 ;;=HEMATOLOGY/ONCOLOGY^21^42
 ;;^UTILITY(U,$J,358.4,499,0)
 ;;=HISTORY OF ILLNESS^22^42
 ;;^UTILITY(U,$J,358.4,500,0)
 ;;=INFECTIOUS DISEASE^23^42
 ;;^UTILITY(U,$J,358.4,501,0)
 ;;=LIVER DISEASE^24^42
 ;;^UTILITY(U,$J,358.4,502,0)
 ;;=MENTAL HEALTH^26^42
 ;;^UTILITY(U,$J,358.4,503,0)
 ;;=MOVEMENT DISORDERS^27^42
 ;;^UTILITY(U,$J,358.4,504,0)
 ;;=MUSCULOSKELETAL^28^42
 ;;^UTILITY(U,$J,358.4,505,0)
 ;;=NEUROLOGY^29^42
 ;;^UTILITY(U,$J,358.4,506,0)
 ;;=PAIN^30^42
 ;;^UTILITY(U,$J,358.4,507,0)
 ;;=PREVENTIVE HEALTH^31^42
 ;;^UTILITY(U,$J,358.4,508,0)
 ;;=PULMONARY^32^42
 ;;^UTILITY(U,$J,358.4,509,0)
 ;;=SEXUAL TRAUMA^33^42
 ;;^UTILITY(U,$J,358.4,510,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^34^42
 ;;^UTILITY(U,$J,358.4,511,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^35^42
 ;;^UTILITY(U,$J,358.4,512,0)
 ;;=SUBSTANCE DISORDERS^36^42
 ;;^UTILITY(U,$J,358.4,513,0)
 ;;=VARICOSE VEINS^37^42
 ;;^UTILITY(U,$J,358.4,514,0)
 ;;=WOMEN'S HEALTH^38^42
 ;;^UTILITY(U,$J,358.4,515,0)
 ;;=WOUNDS/INJURIES^39^42
 ;;^UTILITY(U,$J,358.4,516,0)
 ;;=COMA^8^42
 ;;^UTILITY(U,$J,358.4,517,0)
 ;;=CAUSES OF INJURY^6^42
 ;;^UTILITY(U,$J,358.4,518,0)
 ;;=DEMENTIA^9^42
 ;;^UTILITY(U,$J,358.4,519,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^25^42
 ;;^UTILITY(U,$J,358.4,520,0)
 ;;=CHEST PAIN^7^42
 ;;^UTILITY(U,$J,358.4,521,0)
 ;;=ESTABLISHED PATIENT^2^43
 ;;^UTILITY(U,$J,358.4,522,0)
 ;;=WORK/DISABILITY^1^43
 ;;^UTILITY(U,$J,358.4,523,0)
 ;;=NEW PATIENT^3^43
 ;;^UTILITY(U,$J,358.4,524,0)
 ;;=IMMUNIZATION^2^44
 ;;^UTILITY(U,$J,358.4,525,0)
 ;;=SKIN TEST^9^44
 ;;^UTILITY(U,$J,358.4,526,0)
 ;;=LACERATION REPAIR/SUTURES^3^44
 ;;^UTILITY(U,$J,358.4,527,0)
 ;;=OTHER^4^44
 ;;^UTILITY(U,$J,358.4,528,0)
 ;;=FOREIGN BODY REMOVAL^1^44
 ;;^UTILITY(U,$J,358.4,529,0)
 ;;=PREVENTIVE MEDICINE-EST PT^5^44
 ;;^UTILITY(U,$J,358.4,530,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^6^44
 ;;^UTILITY(U,$J,358.4,531,0)
 ;;=SCREENING RESULTS^8^44
 ;;^UTILITY(U,$J,358.4,532,0)
 ;;=PROLONGED CLINICAL STAFF TIME^7^44
 ;;^UTILITY(U,$J,358.4,533,0)
 ;;=INJURIES^7^45
 ;;^UTILITY(U,$J,358.4,534,0)
 ;;=EMPLOYEE HEALTH COMMON DX^1^45
 ;;^UTILITY(U,$J,358.4,535,0)
 ;;=EXAMINATIONS^4^45
